Identifying inflammatory bowel disease patients at risk of metabolic dysfunction-associated fatty liver disease: usefulness of non-invasive steatosis predictive scores

Identifying inflammatory bowel disease patients at risk of metabolic dysfunction-associated fatty liver disease: usefulness of non-invasive steatosis predictive scores

Abstract Background Inflammatory bowel disease (IBD) patients have a higher risk of metabolic dysfunction-associated fatty liver disease (MAFLD) compared with the general population. However, it is not known whether available non-invasive hepatic steatosis scores are useful in predicting MAFLD in IB...

Full description

Bibliographic Details
Main Authors: Tiago Lima Capela, Vítor Macedo Silva, Marta Freitas, Cátia Arieira, Tiago Cúrdia Gonçalves, Francisca Dias de Castro, Joana Magalhães, José Cotter
Format: Article
Language:English
Published: BMC 2023-12-01
Series:BMC Gastroenterology
Subjects:
Metabolic dysfunction-associated fatty liver disease
Inflammatory bowel disease
Nonalcoholic fatty liver disease
Non-invasive scores
Online Access:https://doi.org/10.1186/s12876-023-02988-w

Internet

https://doi.org/10.1186/s12876-023-02988-w

Similar Items